Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's Disease

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Craven, Melanie ^a   Egan, Charlotte E ^a   Dowd, Scot E ^b   McDonough, Sean P ^a   Dogan, Belgin ^a   Denkers, Eric Y ^a   Bowman, Dwight ^a   Scherl, Ellen J ^c   Simpson, Kenneth W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MR DNA (Molecular Research)   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE RECEPTOR CCR2; DNA 16S; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM EXAMINATION; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DYSBIOSIS; ESCHERICHIA COLI; FEMALE; FIRMICUTES; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GIARDIA MURIS; HOST PATHOGEN INTERACTION; HOST SUSCEPTIBILITY; ILEITIS; INTESTINE FLORA; MICROBIAL DIVERSITY; MICROBIOME; MOUSE; NONHUMAN; ORGANISMAL INTERACTION; PATHOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PROTEOBACTERIA; PYROSEQUENCING; RISK FACTOR; TOXOPLASMA GONDII;

ANIMALS; BACTERIAL TRANSLOCATION; CROHN DISEASE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GIARDIA; GIARDIASIS; HUMANS; ILEITIS; INFLAMMATION; MICE; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CCR2; TOXOPLASMA; TOXOPLASMOSIS;

BACTERIA (MICROORGANISMS); FIRMICUTES; GIARDIA MURIS; MURINAE; MUS; PROTEOBACTERIA; TOXOPLASMA GONDII;

EID: 84864366225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041594     Document Type: Article

References (61)

1. Abraham C, Cho JH, (2009) Inflammatory bowel disease. N Engl J Med 361(21): 2066-2078.
2. Hanauer SB, (2006) Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12: S3-9.
3. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152): 427-434.
4. Sartor RB, (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2): 577-594.
5. Singh S, Graff LA, Bernstein CN, (2009) Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 104(5): 1298-313; quiz 1314.
6. Van Limbergen J, Wilson DC, Satsangi J, (2009) The genetics of crohn's disease. Annu Rev Genomics Hum Genet 10: 89-116.
7. Packey CD, Sartor RB, (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22(3): 292-301.
8. Molodecky NA, Kaplan GG, (2010) Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 6(5): 339-346.
9. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, et al. (2010) A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 105(9): 1994-2002.
10. Mann EA, Saeed SA, (2011) Gastrointestinal infection as a trigger for inflammatory bowel disease. Curr Opin Gastroenterol.
11. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP, (2004) Differential effects of NOD2 variants on crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 99(12): 2393-2404.
12. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. implications for crohn's disease. J Biol Chem 278(8): 5509-5512.
13. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, et al. (2005) Nod2 mutation in crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307(5710): 734-738.
14. Eckmann L, Karin M, (2005) NOD2 and crohn's disease: Loss or gain of function? Immunity 22(6): 661-667.
15. Perez LH, Butler M, Creasey T, Dzink-Fox J, Gounarides J, et al. (2010) Direct bacterial killing in vitro by recombinant Nod2 is compromised by crohn's disease-associated mutations. PLoS One 5(6): e10915.
16. Massey DC, Parkes M, (2007) Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with crohn's disease. Autophagy 3(6): 649-651.
17. Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, et al. (2008) Contributions of IBD5, IL23R, ATG16L1, and NOD2 to crohn's disease risk in a population-based case-control study: Evidence of gene-gene interactions. Inflamm Bowel Dis 14(11): 1528-1541.
18. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122(1): 44-54.
19. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, et al. (1991) Effect of faecal stream diversion on recurrence of crohn's disease in the neoterminal ileum. Lancet 338(8770): 771-774.
20. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, et al. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive escherichia coli of novel phylogeny relative to depletion of clostridiales in crohn's disease involving the ileum. ISME J 1(5): 403-418.
21. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, et al. (1998) Presence of adherent escherichia coli strains in ileal mucosa of patients with crohn's disease. Gastroenterology 115(6): 1405-1413.
22. Martinez-Medina M, Aldeguer X, Lopez-Siles M, Gonzalez-Huix F, Lopez-Oliu C, et al. (2009) Molecular diversity of escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in crohn's disease. Inflamm Bowel Dis 15(6): 872-882.
23. Barnich N, Darfeuille-Michaud A, (2007) Adherent-invasive escherichia coli and crohn's disease. Curr Opin Gastroenterol 23(1): 16-20.
24. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A, (2010) Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 12(1): 99-113.
25. Meconi S, Vercellone A, Levillain F, Payre B, Al Saati T, et al. (2007) Adherent-invasive escherichia coli isolated from crohn's disease patients induce granulomas in vitro. Cell Microbiol 9(5): 1252-1261.
26. Liesenfeld O, (2002) Oral infection of C57BL/6 mice with toxoplasma gondii: A new model of inflammatory bowel disease? J Infect Dis 185: S96-101.
27. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, et al. (2007) Exacerbation of murine ileitis by toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal escherichia coli. Gut 56(7): 941-948.
28. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, et al. (2006) Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with toxoplasma gondii. J Immunol 177(12): 8785-8795.
29. Gillon J, Thamery D AL, Ferguson A, (1982) Features of small intestinal pathology (epithelial cell kinetics, intraepithelial lymphocytes, disaccharidases) in a primary Giardia muris infection. Gut 23(6): 498-506.
30. Scott KG, Yu LC, Buret AG.Role of CD8+ and CD4+ T lymphocytes in jejunal mucosal injury during murine giardiasis (2004) Infect Immun 72(6): 3536-42.
31. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, et al. (2008) Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 57(2): 181-7.
32. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, et al. (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4): 444-453.
33. Gontcharova V, Youn E, Sun Y, Wolcott RD, Dowd SE, (2010) A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J 4: 8-19.
34. Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, et al. (2009) The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol 9: 210.
35. Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaessig S, et al. (2006) Adherent and invasive escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 74(8): 4778-4792.
36. Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S, (2004) Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: A global approach to the enteric flora. J Clin Microbiol 42(6): 2566-2572.
37. DebRoy C, Maddox CW, (2001) Identification of virulence attributes of gastrointestinal escherichia coli isolates of veterinary significance. Anim Health Res Rev 2(2): 129-140.
38. Bach S, de Almeida A, Carniel E, (2000) The yersinia high-pathogenicity island is present in different members of the family enterobacteriaceae. FEMS Microbiol Lett 183(2): 289-294.
39. Germon P, Chen YH, He L, Blanco JE, Bree A, et al. (2005) ibeA, a virulence factor of avian pathogenic escherichia coli. Microbiology 151(Pt 4): 1179-1186.
40. Johnson JR, Stell AL, (2000) Extended virulence genotypes of escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181(1): 261-272.
41. Egan CE, Craven MD, Leng J, Mack M, Simpson KW, et al. (2009) CCR2-dependent intraepithelial lymphocytes mediate inflammatory gut pathology during toxoplasma gondii infection. Mucosal Immunol 2(6): 527-535.
42. Jones J, Panaccione R, (2008) Biologic therapy in crohn's disease: State of the art. Curr Opin Gastroenterol 24(4): 475-481.
43. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34): 13780-13785.
44. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP, (2005) Spatial organization of bacterial flora in normal and inflamed intestine: A fluorescence in situ hybridization study in mice. World J Gastroenterol 11(8): 1131-1140.
45. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal crohn's disease. Inflamm Bowel Dis 15(5): 653-660.
46. Mizoguchi A, Mizoguchi E, (2010) Animal models of IBD: Linkage to human disease. Curr Opin Pharmacol 10(5): 578-587.
47. Takeuchi K, Smale S, Premchand P, Maiden L, Sherwood R, et al. (2006) Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4(2): 196-202.
48. Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, et al. (2000) Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: A case-control study. Am J Gastroenterol 95(8): 1949-1954.
49. Ramasundara M, Leach ST, Lemberg DA, Day AS, (2009) Defensins and inflammation: The role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol 24(2): 202-208.
50. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive escherichia coli associated with ileal mucosa in crohn's disease. Gastroenterology 127(2): 412-421.
51. Bringer MA, Rolhion N, Glasser AL, Darfeuille-Michaud A, (2007) The oxidoreductase DsbA plays a key role in the ability of the crohn's disease-associated adherent-invasive escherichia coli strain LF82 to resist macrophage killing. J Bacteriol 189(13): 4860-4871.
52. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, et al. (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in crohn disease. J Clin Invest 117(6): 1566-1574.
53. Rolhion N, Barnich N, Bringer MA, Glasser AL, Ranc J, et al. (2010) Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive escherichia coli invasion. Gut 59(10): 1355-1362.
54. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, et al. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 106(37): 15813-15818.
55. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, et al. (2002) The molecular classification of the clinical manifestations of crohn's disease. Gastroenterology 122(4): 854-866.
56. Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, et al. (2008) Molecular analysis of the gut microbiota of identical twins with crohn's disease. ISME J 2(7): 716-727.
57. Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, et al. (2004) CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in crohn's disease. Gut 53(9): 1287-1294.
58. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for crohn's disease. Nat Genet 40(8): 955-962.
59. Palmieri O, Latiano A, Salvatori E, Valvano MR, Bossa F, et al. (2010) The-A2518G polymorphism of monocyte chemoattractant protein-1 is associated with crohn's disease. Am J Gastroenterol 105(7): 1586-1594.
60. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, et al. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116(1): 115-124.
61. Bringer MA, Billard E, Glasser AL, Colombel JF. Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion, (2012) Lab Invest. 92(3): 411-9.